Associated Banc-Corp’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,955
Closed -$204K 319
2024
Q1
$204K Hold
2,955
0.01% 306
2023
Q4
$219K Sell
2,955
-160
-5% -$10.5K 0.01% 297
2023
Q3
$213K Buy
3,115
+150
+5% +$12.7K 0.01% 289
2023
Q2
$278K Sell
2,965
-50
-2% -$3.9K 0.01% 269
2023
Q1
$204K Buy
+3,015
New +$194K 0.01% 301
2022
Q2
Sell
-3,382
Closed -$236K 309
2022
Q1
$236K Hold
3,382
0.01% 294
2021
Q4
$263K Hold
3,382
0.01% 289
2021
Q3
$323K Hold
3,382
0.01% 265
2021
Q2
$420K Buy
+3,382
New +$404K 0.02% 247
2021
Q1
Sell
-3,398
Closed -$450K 490
2020
Q4
$450K Buy
3,398
+16
+0.5% +$1.94K 0.02% 285
2020
Q3
$345K Sell
3,382
-39
-1% -$3.37K 0.01% 289
2020
Q2
$297K Buy
3,421
+3,378
+7,856% +$270K 0.01% 297
2020
Q1
$2K Sell
43
-2,304
-98% -$187K ﹤0.01% 568
2019
Q4
$217K Hold
2,347
0.01% 292
2019
Q3
$212K Buy
2,347
+105
+5% +$12K 0.01% 283
2019
Q2
$265K Sell
2,242
-100
-4% -$10.1K 0.01% 259
2019
Q1
$203K Buy
+2,342
New +$199K 0.01% 264

Other funds holding EXAS

Associated Banc-Corp's EXAS Position: Q2 2024 in Review

Associated Banc-Corp sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 2,955 shares — an estimated $204K sold.

Associated Banc-Corp first reported a position in EXAS in Q1 2019 and held it in 17 quarters. The position peaked at $450K in Q4 2020. 543 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Associated Banc-Corp reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Associated Banc-Corp sold 2,955 Exact Sciences shares in Q2 2024, an estimated $204K.
  • Associated Banc-Corp first reported a position in Exact Sciences in Q1 2019 and held it in 17 quarters.
  • Associated Banc-Corp's Exact Sciences position peaked at $450K in Q4 2020.
  • 543 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Associated Banc-Corp's 13F filing for Q2 2024, filed 1 Aug 2024.